3
b. + nanoprobe
c. + nanoprobe
Red channel
Bright field
Overlay
a. Controlgroup
.07%
11.5%
without irradiation
under irradiation
1
e6
1
e6
1
e5
e4
12.9%
42%
0
1e5
1e5
1e4
1e3
1
1
e4
e3
1
e3
00
88.8%
1
69.6%
11.9%
19.2%
37.5%
1
a
b
100
100
1
0
10
0
1
0
0
0
0
10 100 1e3 1e4 1e5
FITC
0 101001e3 1e4 1e5
FITC
0
101001e31e41e51e6
FITC
Fig. 6 Flow cytometry analysis of cell death induced by the nanoprobe-
mediated PDT.
generation of the nanoprobe in cells under irradiation. When the
nanoprobe incubated cells were treated with DCFH-DA for 5 min,
the luminescence from the emission channel (505 525 nm) was
detected after white light irradiation (100 mW cm ) for 5 min
Fig. S6c in Supporting information). We also conducted the
-2
(
similar experiments using blank cells or the nanoprobe loading
cells without irradiation (Fig. S6a-b in Supporting information).
The relatively weak luminescence was observed in these control
groups (Fig. S7 in Supporting information), which demonstrated
that the emission enhancement was attributed to the nanoprobe
induced photodamage.
Fig. 4 Confocal laser scanning microscopy images of HeLa cells incubated
-
1
without (a) and with (b) the nanoprobe (18 g mL ). The image of left
column collected the emission from 580 650 nm; Excitation wavelength
was 405 nm. The middle column is bright field image. The right column is
the overlay image.
of 1 were not affected when it was encapsulated into the
Furthermore, the anticancer effects of the nanoprobe were
investigated using HeLa cells as a model. The cell death induced
by the nanoprobe mediated PDT was studied using two
fluorescent indicators, Annexin V-FITC/propidium iodide(PI)
that enable to monitor and differentiate the cellular apoptotic
stages. As illustrated in Fig. 5, different from the blank cells and
the nanoprobe loading cells in dark, cells treated with the
nanoprobe followed by irradiation exhibited bright green
fluorescence from Annexin V-FITC in the cell membrane and red
fluorescence from PI in the cell nucleus. These results suggested
the good anticancer efficiency of the nanoprobe. Additionally, the
real-time imaging was conducted to monitor the long-term
cellular apoptosis process (Fig. S8 in Supporting information).
The cells showed green fluorescence after 1 h, which proved that
the early apoptosis occurred in cells. After 2.5 h, we observed the
cells death, resulting in the enhancement of red emission in
nucleus.
nanostructure. Additionally, the stable structure of nanoprobe
1
enhanced O
2
generation efficiency of 1 and facilitated the PDT
process in cells.
The cytotoxicity of nanoprobe is essential to be considered
when it was used for the biological applications in cells. We first
examined the influence of the nanoprobe on cell viability through
the 3-(4,5-dimethyl-w-thiazolyl)-2,5-diphenyl-2-H-tetrazolium
bromide (MTT) assay (Fig. S4 in Supporting information). The
-
1
nanoprobe with the concentration ranged from 0 to 400 g mL
was added to the incubation buffer. When the incubation
-1
concentration was increased to 400 g mL , the viability of
HeLa cells remained more than 90% after 24 h, indicating low
cytotoxicity of the nanoprobe. We further used HeLa cells as a
model to study the possibility of utilization of the nanoprobe as a
potential imaging agent via confocal laser scanning microscopy
-1
(
Fig. 4). When cells were treated with the nanoprobe (18 g mL )
for 1 h, intense fluorescence collected from the red channel (em
580 650 nm) was observed in the cytoplasm (Fig. 4b).
The quantitative evaluation of the anticancer effects was also
conducted using flow cytometry. As illustrated in Fig. 6, the
proportion of apoptotic cells was gradually increased when cells
were incubated with the nanoprobe and exposure to light
irradiation for 5 min. The late-stage apoptotic cells reached to
=
Compared to the blank cells, The nanoprobe incubated cells
showed intense fluorescence, excluding the autofluorescence
interference (Fig. 4a, Fig. S5 in Supporting information).
We used 2,7-dichlorifluorescein-diacetate (DCFH-DA) as an
42%, which were sharply increased compared to the control
indicator, which can convert to 2,7-dichlorodihydrofluorescein
1
groups. The results of MTT assay were in agreement with those
detected in flow cytometry (Fig. S9 in Supporting information).
A dose-dependent cytotoxicity was observed in HeLa cells under
irradiation. When the concentration of the nanoprobe incubated
(
DCFH) in cells and undergo oxidation with O
2
to produce
1
fluorescent 2,7-dichlorofluorescein (DCF), to monitor the O
2
Brightfield
FITC
PI
Overlay
-1
was kept at 18 g mL , the varying irradiation time also resulted
in different degree of cell death (Fig. S10 in Supporting
information). These results demonstrated the good therapeutic
efficiency of the nanoprobe.
a. Controlgroup
Conclusions
b. + nanoprobe
without irradiation
In summary, we prepared an organic AIE-active
photosensitizer 1. It owned spatially separated electron donor and
acceptor, leading to low energy gap between the S
1
and T
1
states
1
and thus increased
2
O quantum yields. To stabilize 1 in
c. + nanoprobe
under irradiation
aggregation state and improve the biocompatibility, we
enveloped 1 into a water-soluble nanoprobe and employed the
nanoprobe for PDT process in cells. Different from the traditional
photosensitizer, the nanoprobe overcame the aggregation-induced
quenching in practical biological applications, and showed strong
fluorescence emission, which rendered 1 as a potential imaging
agent. The efficient therapeutic effects detected from the
Fig. 5 Confocal microscopy images of annexin V-FITC- and PI-labeled HeLa
-
1
cells. (a) blank cells; (b) Cells were treated with the nanoprobe (18 g mL )
without irradiation (100 mW cm 5 min); (c) Cells were treated with the
-
2
-
1
-2
nanoprobe (18 g mL ) with irradiation (100 mW cm 5 min).